Renal cancer vaccine - AVAX Technologies
Alternative Names: Kidney cancer vaccine - AVAXLatest Information Update: 17 Mar 2008
At a glance
- Originator AVAX Technologies
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal cancer
Most Recent Events
- 28 Jun 2000 Phase-II clinical trials for Renal cancer in USA (Intradermal)